Reports
Sale
Global Tissue Banking Market Size, Growth, Report, Analysis: By Product: Equipment, Media, Consumables; By Tissue Type: Heart Valves, Cornea, Bone, Skin, Brain and Spinal Cord, Others; By Application: Therapeutic, Cosmetic, Research and Development, Drug Discovery, Others; By End User; Regional Analysis; Competitive Landscape; 2024-2032
Global Tissue Banking Market Outlook
The global tissue banking market size was valued at USD 1.8 billion in 2023, driven by the increasing innovations in medical technologies across the globe. The market size is anticipated to grow at a CAGR of 11.8% during the forecast period of 2024-2032 to achieve a value of USD 4.9 billion by 2032.
Tissue Banking: Introduction
A tissue bank plays a crucial role in gathering and acquiring human cadaver tissue for medical research, educational purposes, and transplant operations. It also involves preserving biomedical tissue under cryogenic conditions for clinical applications. The process of tissue banking is complex and involves collecting, processing, storing, and distributing transplantable human tissues. These tissues are indispensable in repairing or replacing damaged or lost tissues in humans. Furthermore, tissue banking is important in collecting and preserving human tissue and blood samples to advance scientific research.
Global Tissue Banking Market Analysis
The market is experiencing significant growth driven by emerging trends and advancements in medical technologies. The increasing emphasis on ex vivo cord blood expansion holds immense promise in the field of regenerative medicine. Ex vivo cord-blood expansion technologies have the potential to revolutionize tissue grafting and transplantation procedures, providing a wider pool of compatible donors for patients in need. Moreover, these technologies are making strides in addressing critical medical challenges such as treating skin wounds and repairing bone defects resulting from trauma or tumor ablation. With increasing advances, the American Association of Tissue Banks (AATB) released Bulletin 23-6 earlier this year introducing mandatory requirements and recommendations aimed at reducing the risk of tuberculosis (TB) transmission through tissues, ensuring the safety and quality of tissue-based medical interventions.
The rapid advancements in technologies supporting ex vivo cord blood expansion are driving the global tissue banking market growth. These innovations are not only increasing the possibilities of tissue grafting and transplantation but also enhancing the overall safety and effectiveness of tissue-based treatments. With these emerging trends, market growth is driven by increasing demand for advanced tissue products and the growing awareness of their potential to address various medical conditions. Consequently, the market is witnessing a dynamic shift towards cutting-edge solutions that promise to improve patient outcomes and redefine the future of regenerative medicine.
Global Tissue Banking Market Segmentations
Market Breakup by Product
- Equipment
- Media
- Consumables
Market Breakup by Tissue Type
- Heart Valves
- ornea
- Bone
- Skin
- Brain and Spinal Cord
- Others
Market Breakup by Application
- Therapeutic
- Cosmetic
- Research and Development
- Drug Discovery
- Others
Market Breakup by End User
- Biobanks
- Hospitals and Clinics
- Research and Academic Institutes
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Tissue Banking Market Overview
The market is experiencing robust growth driven by factors that show the increasing importance of tissue banking in the healthcare sector. The geriatric population, coupled with a surge in the incidence of chronic diseases such as cardiovascular disease, cancer, diabetes, and various lifestyle disorders, has created a substantial demand for tissue banking services. The geriatric population requires medical interventions that often involve the transplantation of bones, tendons, corneas, heart valves, and skin. Additionally, the rising healthcare expenditure across the globe has enabled greater accessibility to tissue banking services, adding further value the global tissue banking market share.
Furthermore, tissue banking has also found wide application beyond transplantation. Hospitals, research and academic institutes, and drug discovery centres increasingly rely on tissue banks to support their research and facilitate advancements in medical science. Tissue samples play a pivotal role in understanding the pathology of diseases, drug testing, and developing innovative therapies. The growing burden of chronic diseases necessitates a continuous supply of well-preserved tissue samples for research purposes. Moreover, the practice of biobanking, wherein biological specimens and tissues are collected, processed, and stored for future use, has gained popularity as well. The growth in demand, ranging from transplantation needs to research and drug discovery has established the tissue banking market as a pivotal part of the healthcare sector further propelling the market growth in the coming years.
Geographically, North America is currently leading the regional market and is expected to dominate throughout the forecast period driven by factors such as rising chronic diseases, a growing number of pharmaceutical companies, coupled with an increasing number of research activities in the region as well. The market is also driven by the presence of key market players, and increased acquisitions. Additionally, increased investments from government organizations in upcoming tissue-banking projects are also a major factor propelling market growth.
Global Tissue Banking Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Thermo Fisher Scientific Inc.
- Sigma-Aldrich Co.
- BioLifeSolutions
- Lifeline Scientific
- Cesca Therapeutics, Inc.
- Core Dynamics GmbH
- Custom Biogenic Systems
- Atlanta Biologics Pvt. Ltd.
- Taylor-Wharton
- Panasonic Holdings Corporation
- QIAGEN
- VWR International, LLC
- Eppendorf AG
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Tissue Type |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Tissue Banking Market Overview
3.1 Global Tissue Banking Market Historical Value (2017-2023)
3.2 Global Tissue Banking Market Forecast Value (2024-2032)
4 Global Tissue Banking Market Landscape
4.1 Global Tissue Banking Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Tissue Banking Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Tissue Type
4.2.3 Analysis by Applications
5 Global Tissue Banking Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Tissue Banking Market Segmentation
6.1 Global Tissue Banking Market by Product
6.1.1 Market Overview
6.1.2 Equipment
6.1.3 Media
6.1.4 Consumables
6.2 Global Tissue Banking Market by Tissue Type
6.2.1 Market Overview
6.2.2 Heart Valves
6.2.3 Cornea
6.2.4 Bone
6.2.5 Skin
6.2.6 Brain and Spinal Cord
6.2.7 Others
6.3 Global Tissue Banking Market by Application
6.3.1 Market Overview
6.3.2 Therapeutic
6.3.3 Cosmetic
6.3.4 Research and Development
6.3.5 Drug Discovery
6.3.6 Others
6.4 Global Tissue Banking Market by End User
6.4.1 Market Overview
6.4.2 Biobanks
6.4.3 Hospitals and Clinics
6.4.4 Research and Academic Institutes
6.4.5 Others
6.5 Global Tissue Banking Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Tissue Banking Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Tissue Banking Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Tissue Banking Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Tissue Banking Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Tissue Banking Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Thermo Fisher Scientific Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Sigma-Aldrich Co.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 BioLifeSolutions
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Lifeline Scientific
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Cesca Therapeutics, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Core dynamics GmbH
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Custom Biogenic Systems
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Atlanta Biologics Pvt. Ltd.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Taylor-Wharton
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Panasonic Holdings Corporation
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 QIAGEN
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 VWR International, LLC
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Eppendorf AG
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
18 Global Tissue Banking Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 1.8 billion in 2023, driven by the rising prevalence of chronic disorders across the globe.
The market is anticipated to grow at a CAGR of 11.8% during the forecast period of 2024-2032, likely to reach a market value of USD 4.9 billion by 2032.
The increasing geriatric population and increasing awareness about the importance of tissue banking are major factors driving the market growth.
The rising practice of biobanking is a major trend influencing the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
Different products in the market include equipment, media, and consumables.
Tissue types include heart valves, cornea, bone, brain and spinal cord, and skin.
It finds application in therapeutic, cosmetic, research and development, and drug discovery, among others.
End users in the market are biobanks, hospitals and clinics, research and academic institutes, among others.
Key players involved in the market are Thermo Fisher Scientific Inc., Sigma-Aldrich Co., BioLifeSolutions, Lifeline Scientific, Cesca Therapeutics, Inc., Core Dynamics GmbH, Custom Biogenic Systems, Atlanta Biologics Pvt. Ltd., Taylor-Wharton, Panasonic Holdings Corporation, QIAGEN, VWR International, LLC, and Eppendorf AG.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER